Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Scientific Reports|October 18, 2019
Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolismKenji Nishimura, Taichi Murakami, Toshihiro Sakurai, et al.
The Journal of Biological Chemistry|April 8, 2011
Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathyTatsuya Tominaga, Hideharu Abe, Otoya Ueda, et al.
Scientific Reports|December 29, 2019
Author Correction: Circulating Apolipoprotein L1 is associated with insulin resistance-induced abnormal lipid metabolismKenji Nishimura, Taichi Murakami, Toshihiro Sakurai, et al.
The Journal of Medical Investigation : JMI|October 29, 2019
Adult onset of Immunoglobulin A vasculitis - A case reportShusuke Yagi, Itsuro Endo, Taichi Murakami, et al.
BMC Nephrology|August 5, 2017
Successful treatment of highly advanced immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure: a case studyHiroyuki Ono, Taichi Murakami, Akira Mima, et al.
The Journal of Medical Investigation : JMI|October 5, 2018
Urinary Exosomal mRNA of WT1 as Diagnostic and Prognostic Biomarker for Diabetic NephropathyHideharu Abe, Akiko Sakurai, Hiroyuki Ono, et al.
Artificial Organs|May 6, 2015
Re-evaluation of Pre-pump Arterial Pressure to Avoid Inadequate Dialysis and Hemolysis: Importance of Prepump Arterial Pressure Monitoring in Hemodialysis PatientsEriko Shibata, Kojiro Nagai, Risa Takeuchi, et al.
The Journal of Medical Investigation : JMI|May 9, 2019
The utility and limitation of inferior vena cava diameter as a dry weight markerEriko Shibata, Kojiro Nagai, Sayo Ueda, et al.
The Journal of Biological Chemistry|July 29, 2011
SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathySeiji Kishi, Hideharu Abe, Haruhiko Akiyama, et al.
The Journal of Medical Investigation : JMI|November 5, 2020
Clinical characteristics associated with 1-year tolvaptan efficacy in autosomal dominant polycystic kidney disease with a wide range of kidney functionsTaichi Murakami, Kenji Nishimura, Hiroyuki Ono, et al.
Pageof 5